CD8A and neoplasm: The latter's research were also perfectly correlated with another recent one indicating that a blockade of TIM3 could not only increase antitumor CD8 T cells activation and IFN‐γ secretion, but would also favour cDC1 cells and CD8 T cells to colocalize within the tumour, amplifying the chance to mount an appropriate antitumor response both in time and space (Gardner et al., 2022).